Associate Editor Disclosures

Editor-In-Chief

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO, has served as a consultant for Bristol Myers Squibb, Karyopharm Therapeutics, and Sanofi.

Associate Editors

Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, has no conflicts of interest to disclose.

Carolyn Grande, CRNP, AOCNP®, has served as a consultant for AstraZeneca and Pfizer.

Kirollos Hanna, PharmD, BCPS, BCOP, has served as a consultant for AbbVie and Seattle Genetics, on advisory boards for AstraZeneca, Heron Therapeutics, Incyte, Rigel, Sandoz, Taiho Oncology, on the speakers bureaus for AbbVie, Astellas, BeiGene, Bristol Myers Squibb, and Seattle Genetics, and holds stock in CVS Health.

Lindsey Lyle, MS, PA-C, has served as a consultant for Agios, Celgene, Incyte Corporation, Novartis, Takeda Oncology, and Pfizer.

Beth Sandy, MSN, CRNP, OCN®, has served on speakers bureaus for AbbVie, AstraZeneca, Helsinn, Merck, and Takeda.

Constance Visovsky, PhD, RN, ACNP-BC, has no conflicts of interest to disclose.

Wendy H. Vogel, MSN, FNP, AOCNP®, FAPO, has no conflicts of interest to disclose.

Steven H. Wei, MS, MPH, PA-C, DFAAPA, has no conflicts of interest to disclose.